Research Article

Association of Toll-Like Receptor 4 Gene Polymorphisms with Acute Aortic Dissection in a Chinese Han Population

Table 4

The interaction effects between TLR4 polymorphisms and risk factors in the susceptibility to AAD.

SNP genotypesNumber of subjectsObesityaSmokingbDrinkingcHypertensiondDyslipidemiae
NoYesNoYesNoYesNoYesNoYes
rs10759932
CC+TCNo. of controls/cases99/7528/2759/7349/3669/8339/2672/1757/9669/5060/61
OR (95% CI)1.0 (ref.)1.234 (0.651-2.337)1.0 (ref.)0.564 (0.319-0.997)1.0 (ref.)0.497 (0.268-0.922)1.0 (ref.)7.250 (3.662-14.353)1.0 (ref.)1.433 (0.825-2.488)
TTNo. of controls/cases74/6914/2653/6932/3553/7132/3357/2936/7752/5740/43
1.035 (0.646-1.659)1.952 (0.940-4.056)0.954 (0.563-1.616)0.837 (0.456-1.537)1.065 (0.643-1.764)0.716 (0.388-1.322)1.657 (0.745-3.687)7.812 (3.829-15.940)1.360 (0.769-2.405)1.377 (0.748-2.533)
OR (95% CI)
, (0.377-3.830), (0.624-4.546), (0.376-3.035), (0.267-2.105), (0.263-1.798)
CCNo. of controls/cases24/1210/416/1112/819/139/620/214/1720/814/11
OR (95% CI)1.0 (ref.)0.768 (0.191-3.089)1.0 (ref.)0.889 (0.248-3.183)1.0 (ref.)0.768 (0.191-3.089)1.0 (ref.)10.045 (1.890-53.403)1.0 (ref.)3.667 (0.934-14.392)
TC+TTNo. of controls/cases149/13232/4996/13169/63103/14162/53109/4479/156101/9986/93
OR (95% CI)1.620 (0.741-3.545)2.740 (1.141-6.579)2.197 (0.927-5.209)1.469 (0.604-3.572)2.213 (1.005-4.872)1.226 (0.531-2.831)2.965 (0.647-13.597)16.174 (3.635-71.956)4.047 (1.300-12.603)4.438 (1.419-13.883)
, (0.320-10.550), (0.147-3.616), (0.074-2.533), (0.104-4.237), (0.047-1.428)
rs11536889
GGNo. of controls/cases117/9632/3979/9251/5484/10446/4286/2668/12287/6466/78
OR (95% CI)1.0 (ref.)1.473 (0.833-2.605)1.0 (ref.)0.886 (0.532-1.473)1.0 (ref.)0.623 (0.363-1.068)1.0 (ref.)7.041 (3.785-13.097)1.0 (ref.)1.545 (0.938-2.548)
CC+GCNo. of controls/cases53/5010/1533/5128/1938/5123/1941/2024/5433/4532/27
OR (95% CI)1.049 (0.638-1.718)1.561 (0.659-3.694)1.333 (0.760-2.337)0.583 (0.295-1.154)1.061 (0.622-1.809)0.604 (0.298-1.223)1.618 (0.724-3.616)7.596 (3.651-15.802)1.500 (0.824-2.729)1.034 (0.543-1.972)
, (0.305-4.069), (0.118-1.011), (0.172-1.646), (0.245-2.078), (0.146-1.166)
GC+GGNo. of controls/cases164/13641/51106/13478/67116/14368/58124/4287/164113/10197/97
OR (95% CI)1.0 (ref.)1.463 (0.895-2.393)1.0 (ref.)0.664 (0.431-1.022)1.0 (ref.)0.603 (0.384-0.948)1.0 (ref.)5.873 (3.603-9.572)1.0 (ref.)1.071 (0.714-1.605)
CCNo. of controls/cases6/101/36/91/66/121/33/45/127/81/8
OR (95% CI)1.805 (0.575-5.660)3.384 (0.348-32.950)1.053 (0.312-3.554)4.386 (0.504-38.175)1.571 (0.511-4.829)1.746 (0.156-19.519)1.613 (0.141-18.395)8.065 (2.363-27.523)1.143 (0.371-3.524)7.838 (0.962-63.858)
, (0.066-15.184), (0.456-86.754), (0.136-53.671), (0.076-21.291)(0.076#),(1.156-200.621)

a for association was adjusted by age, sex, smoking, drinking, hypertension, diabetes, and dyslipidemia. b for association was adjusted by age, sex, obesity, drinking, hypertension, diabetes, and dyslipidemia. c for association was adjusted by age, sex, obesity, smoking, hypertension, diabetes, and dyslipidemia. d for association was adjusted by age, sex, obesity, smoking, drinking, diabetes, and dyslipidemia. e for association was adjusted by age, sex, obesity, smoking, drinking, hypertension, and diabetes. # value after Bonferroni correction. The results are in bold if .